B60.02
Babesiosis due to Babesia duncani
Clinical Classification Guidelines
Inclusion Terms
- Infection due to B. duncani and B. duncani-type species
Medical Intelligence & Overview
Babesiosis is a malaria-like illness caused by microscopic parasites of the genus Babesia. Specifically, when babesiosis is due to Babesia duncani, it indicates an infection with a parasite that is primarily found in the western United States. This condition is transmitted through ticks and can lead to a range of health issues. Understanding the causes, symptoms, and treatment options for babesiosis caused by B. duncani is essential for those at risk or diagnosed with the condition.
Causes & Symptoms
Clinical Causes: Transmission primarily occurs through bites from infected ticks, particularly the black-legged tick (Ixodes scapularis). People who spend time in wooded or grassy areas where ticks are prevalent are at increased risk. Contamination can also occur through blood transfusions or, rarely, from mother to child during pregnancy.
Key Symptoms: Fever and chills Sweating Fatigue and weakness Muscle aches Headache Loss of appetite Sweating during episodes of fever Jaundice (yellowing of skin and eyes) in severe cases Enlarged spleen or liver in some cases Anemia due to destruction of red blood cells
Diagnostic & Treatment
Diagnosis Path: Diagnosis of babesiosis involves a combination of clinical evaluation and laboratory tests. Blood smears examined under a microscope can reveal the presence of the Babesia parasites within red blood cells. Additional tests such as polymerase chain reaction (PCR) can identify Babesia DNA, confirming the infection. Blood tests may also show anemia and other related abnormalities. A detailed patient history, including recent tick exposure and travel, supports the diagnosis.
Treatment Protocols: Treating babesiosis caused by B. duncani typically involves specific antimicrobial medications. Common treatments include the combination of atovaquone and azithromycin, which effectively target the parasites. In severe cases or in immunocompromised patients, clindamycin with quinine may be used. Supportive care includes managing symptoms like fever and anemia. It is important for patients to complete the full course of treatment and follow healthcare provider recommendations for monitoring and recovery. In some instances, additional therapies may be necessary based on the severity of the infection.
Clinical Advice & FAQs
Billing Guidance
Is B60.02 a billable ICD-10 code?
Yes, B60.02 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B60.02?
Clinical documentation must specify the nature of Babesiosis due to Babesia duncani and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
